Cambridge Healthtech Institute’s 4^th Annual

Adoptive T-Cell Therapy

Effective and Unconventional Strategies

21-22 March 2019

The therapeutic potential of adoptive T-cell therapy was first acknowledged couple decades ago, but it was only last year that we have transformed adoptive T-cell therapy into a viable therapeutic option for patients by the two CAR T-cell therapies approved by the FDA. Although this is a very exciting time for adoptive T-cell therapy, there is still much to be done to reach its full potential. Cambridge Healthtech Institute’s 4^th Annual Adoptive T-Cell Therapy will gather experts in the field to address clinical progress, discuss strategies to reduce toxicity, increase efficacy, production and cost-effectiveness along with showcasing emerging unconventional T cell therapies.  

Coverage will include, but is not limited to:

• New approaches for CAR T engineering
• Strategies for solid tumor
• Technologies, new platforms and preclinical models that enable CAR T development
• Development of allogenate T-cell from healthy donors
• Understanding, prediction and overcoming resistant mechanism
• Tumor-infiltrating Lymphocyte (TIL) therapy
• Unconventional CAR T cells such as NK T cells and gamma delta cells
• Management of toxicities including cytokine release and neurologic toxicity and safety prediction

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for priority consideration is 10 September 2018.

All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:
Emily Le

Conference Producer

Cambridge Healthtech Institute

Phone: (+1) 781-247-1812
Email: ele@healthtech.com

For partnering and sponsorship information, please contact:
Rod Eymael

Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-247-6286
Email: reymael@healthtech.com